Liakou Aikaterini I, Tsantes Andreas G, Routsi Eleni, Agiasofitou Efthymia, Kalamata Magdalini, Bompou Evangelia-Konstantina, Tsante Konstantina A, Vladeni Soultana, Chatzidimitriou Eleni, Kotsafti Ourania, Samonis George, Bonovas Stefanos, Stratigos Alexander I
1st Department of Dermatology-Venereology, "Andreas Sygros" Hospital, National and Kapodistrian University of Athens Medical School, 16121 Athens, Greece.
Laboratory of Haematology and Blood Bank Unit, "Attikon" Hospital, National and Kapodistrian University of Athens Medical School, 12462 Athens, Greece.
J Clin Med. 2024 Aug 7;13(16):4617. doi: 10.3390/jcm13164617.
Exacerbations and new onset of immune-mediated inflammatory diseases, such as psoriasis and hidradenitis suppurativa, have been reported following COVID-19 vaccination. In patients with hidradenitis suppurativa, recent studies have shown that those who received mRNA vaccines were 3.5 times as likely to develop flares following vaccination compared to patients who received non-mRNA vaccines, indicating that mRNA COVID-19 vaccines are associated with hidradenitis suppurativa flares. Similar findings have been found in other studies evaluating the association between COVID-19 vaccines and other immune-mediated inflammatory diseases such as psoriasis, atopic dermatitis, lichen planus, and alopecia areata. However, further research is warranted in larger populations to validate these findings.
据报道，接种新冠疫苗后会出现免疫介导的炎症性疾病的加重和新发情况，如银屑病和化脓性汗腺炎。在化脓性汗腺炎患者中，最近的研究表明，与接种非mRNA疫苗的患者相比，接种mRNA疫苗的患者在接种后出现病情发作的可能性是其3.5倍，这表明新冠mRNA疫苗与化脓性汗腺炎发作有关。在其他评估新冠疫苗与其他免疫介导的炎症性疾病（如银屑病、特应性皮炎、扁平苔藓和斑秃）之间关联的研究中也发现了类似的结果。然而，有必要在更大规模的人群中进行进一步研究以验证这些发现。
